Compartmentalization of Intrarenal Programmed Cell Death Protein 1-Ligand 1 and Its Receptor in Kidney Injury Related to Immune Checkpoint Inhibitor Nephrotoxicity

BACKGROUND: Due to advances in cancer therapy, immune checkpoint inhibitors (ICIs) are new classes of drugs targeting programmed cell death protein 1-ligand 1 (PD-L1) or its receptor (PD-1) used in many cancer therapies. Acute interstitial nephritis (AIN) is a potential and deleterious immune-relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Tampe, Désirée, Kopp, Sarah Birgit, Baier, Eva, Hakroush, Samy, Tampe, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218249/
https://www.ncbi.nlm.nih.gov/pubmed/35755033
http://dx.doi.org/10.3389/fmed.2022.902256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218249/
https://www.ncbi.nlm.nih.gov/pubmed/35755033
http://dx.doi.org/10.3389/fmed.2022.902256

Ejemplares similares